MYD88 and infection: Since the USP7-mediated deubiquitination of MyD88 results in greater stability of MyD88 protein, and an uncontrolled innate immune response always results in greater susceptibility to infection, we speculated that P5091-treated mice would also exhibit less severe inflammatory responses.